Options Update: Myriad Genetics (MYGN) & Potash (POT)
Myriad Genetics (MYGN)
MYGN June Volatility At 91 Into Alzheimer's Data
MYGN closed at $48.03.
MYGN's Flurizan (treatment for Alzheimer's disease) top-line results are expected to be released in mid-June.
MYGN June option implied volatility of 91 is above its 6-month average of 63, suggesting larger price movement.
Potash (POT)
POT Volatility Flat; Shares At Record Level
POT closed at $218.85.
POT over all option implied volatility of 54 is near its 26-week average, suggesting non-directional price risks.
"
About Paul Foster
Paul Foster is a former member of the Chicago Board Options Exchange with 21-years of professional experience in the capital markets, investments, trading, corporate finance, arbitrage, options and mergers & acquisitions. His writing about the options market has appeared in a wide variety of publications.
View Paul Foster's post archive >
